NCT06370039: An ongoing trial by Invirsa, Inc.
This trial is completed, but has been granted a delay in reporting its results.
It must report results 10 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06370039 |
|---|---|
| Title | Phase 2, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study of INV-102 Ophthalmic Solution in Adult Subjects With Moderate to Severe Dry Eye Disease |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 27, 2024 |
| Completion date | July 3, 2024 |
| Required reporting date | July 3, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Aug. 11, 2026 |
| Days late | None |